MAIT Cells in the Bone Marrow of Patients with Aplastic Anemia

被引:0
|
作者
Vu, Lam Quang [1 ]
Espinoza, J. Luis [2 ]
Nguyen, Hoang Thao Giang [2 ]
Mizuno, Shohei [1 ]
Takami, Akiyoshi [1 ]
机构
[1] Aichi Med Univ, Sch Med, Div Hematol, Dept Internal Med, Nagakute 4801195, Japan
[2] Kanazawa Univ, Fac Hlth Sci, Kanazawa 9201192, Japan
关键词
mucosal-associated invariant T cells; aplastic anemia; bone marrow failure; autoimmune disorder; MAIT cells;
D O I
10.3390/ijms251810160
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucosal-associated invariant T cells (MAIT cells) are a subset of T cells with innate, effector-like properties that play an essential role in the immune response to microbial infections. In humans, MAIT cells are detectable in the blood, liver, and lungs, but little is known about the frequency of these cells in the bone marrow. Also, the pathogenic role, if any, of MAIT cells in the development of aplastic anemia, a disease with an exquisite origin in the bone marrow, is currently unknown. We investigated the frequency and clinical relevance of bone marrow MAIT cells in a cohort of 14 patients (60.6 +/- 23 and 57% women) with aplastic anemia. MAIT cells in the bone marrow samples obtained at diagnosis were evaluated by flow cytometry, and their association with various blood cell parameters and the patients' clinical features was analyzed. MAIT cells were detectable in the bone marrow of all patients, with considerable variations among them. Bone marrow MAIT cells expressing the activator receptor natural killer group 2D - NKG2D (NKG2D+ MAIT cells) were significantly more abundant in the specimens of the aplastic anemia patients than in patients with bone marrow failure distinct from aplastic anemia. In addition, the NKG2D+ MAIT cells positively correlated with whole blood cell counts (WBC), platelet counts, and neutrophil counts, as well as with various inflammatory markers, including neutrophil-to-lymphocyte rate (NLR), platelet-to-lymphocyte rate (PLR), and systemic inflammatory index (SII). In functional studies, bone marrow CD34+ hematopoietic cells exposed to phytohemagglutinin or bacterial-derived lipopolysaccharide and acetyl-6-formylpterin upregulated MR1 (major histocompatibility complex, class I-related, known to interact with MAIT cells) and MICA/B (MHC class I chain-related gene A, a ligand of NKG2D) proteins on their cell surface, suggesting that under stress conditions, CD34+ hematopoietic cells are more likely to interact with NKG2D+ MAIT cells. In addition, NKG2D+ MAIT cells upregulated perforin and granzyme B in response to their interaction with recombinant MICA protein in vitro. This study reports for the first time the frequency of MAIT cells in the bone marrow of patients with aplastic anemia and assesses the potential implications of these cells in the pathogenesis or progression of aplastic anemia.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] BONE MARROW TRANSPLANTATION OF APLASTIC ANEMIA FOLLOWING HEPATITIS
    HILGARTNER, MW
    LANZKOWSKY, P
    NACHMAN, RL
    WEKSLER, MB
    PEDIATRIC RESEARCH, 1970, 4 (05) : 468 - +
  • [32] BONE-MARROW TRANSPLANTATION IN APLASTIC-ANEMIA
    BARRETT, AJ
    BRITISH MEDICAL JOURNAL, 1974, 2 (5922): : 40 - 41
  • [33] Multilineage Bone Marrow Response to Eltrombopag in Aplastic Anemia
    Florea, Alina Dulau
    Townsley, Danielle M.
    Dumitriu, Bogdan
    Winkler, Thomas
    Valdez, Janet
    Bolan, Charles
    Dunbar, Cynthia
    Young, Neal
    Braylan, Raul C.
    Calvo, Katherine R.
    MODERN PATHOLOGY, 2016, 29 : 342A - 342A
  • [34] Allogeneic bone marrow transplantation for leukemias and aplastic anemia
    Tsai, TW
    Freytes, CO
    ADVANCES IN INTERNAL MEDICINE, VOL 42, 1997, 42 : 423 - 451
  • [35] Persistent elevated bone marrow plasma levels of thrombopoietin in patients with aplastic anemia
    Zhang, Jizhou
    Wu, Qingqing
    Zheng, Yizhou
    CYTOKINE, 2016, 85 : 11 - 13
  • [36] Alternative donor bone marrow transplantation for patients with severe aplastic anemia.
    Passweg, JR
    Schrezenmeier, H
    Camitta, B
    Socie, G
    Hows, J
    Rowlings, PA
    Horowitz, MM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 180 - 180
  • [37] BONE MARROW IN IRON DEFICIENCY ANEMIA AND HYPOPLASTIC-APLASTIC ANEMIA
    STODTMEISTER, R
    ACTA HAEMATOLOGICA, 1950, 3 (02) : 122 - 123
  • [38] BONE-MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA
    KOLB, HJ
    WUNDISCH, GF
    SPITZER, I
    OCHSLER, H
    STENGELRUTKOWSKI, L
    BENDERGOTZE, C
    ALBERT, ED
    SAUER, H
    LEDDEROSE, G
    BREHM, G
    JEHN, U
    ECKSTEIN, R
    MEMPEL, W
    WILMANNS, W
    HAAS, RJ
    HELMIG, M
    NETZEL, B
    BELOHRADSKY, B
    JANKA, G
    RODT, H
    GROSSEWILDE, H
    THIEL, E
    VONLIEVEN, H
    ROLOFF, R
    KRIMMEL, BL
    BUNDE, E
    WANK, R
    SCHENDEL, D
    KLINISCHE WOCHENSCHRIFT, 1981, 59 (07): : 325 - 342
  • [39] BONE-MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA
    HINTERBERGER, W
    GADNER, H
    HOCKER, P
    SCHMIDMEIER, W
    LECHNER, K
    NEUMANN, E
    NIESSNER, H
    BETTELHEIM, P
    MAYR, W
    HAJEKROSENMAYR, A
    GRANINGER, W
    HAWLICZEK, R
    KARCHER, KH
    BLUT, 1982, 45 (03): : 204 - 205
  • [40] BONE-MARROW TRANSPLANT IN APLASTIC-ANEMIA
    HAAS, RJ
    MONATSSCHRIFT KINDERHEILKUNDE, 1976, 124 (05) : 292 - 294